ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Human CD8+CD28– T Cells Driven In Vitro by IL-15 Suppress in Allo-Specific Manner Partially through PD-1:PD-L1 Pathway

F. Feng,1,2 G. Liu,1 P. Zhu,1 M. Zhu,1 X. Lu,1 J. Liu,2 X. Luo,3 Y. Liu,1 Y. Yu.2

1Department of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China
2Department of Urology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
3Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.

Meeting: 2018 American Transplant Congress

Abstract number: A410

Keywords: Immunosuppression, Tolerance

Session Information

Session Name: Poster Session A: Tolerance / Immune Deviation

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Background: CD8+CD28– T suppressor cells (Ts) have emerged as an important modulator of alloimmunity, but the in vitro inducibility of Ts subsets is rather unclear. Here, we induced rapid expansion of human allospecific CD8+CD28– T cells in vitro by donor APCs plus IL-15, and investigated its immunosuppressive function both in vitro and in vivo circumstances.

Methods: Purified CD8+ T cells from human peripheral blood mononuclear cells (PBMCs) stimulated by APCs (CD2 depleted PBMCs) from HLA-A, B and DR mismatched volunteers were cultured for 9 days in the presence of IL-15. These cells were then analyzed for phenotypic characteristics and the CD28– population was isolated for functional experiment. A CFSE-based CD4+ T cells proliferation assay in vitro was used to assess inhibition of proliferation by CD8+CD28– Ts. The expanded CD8+CD28– Ts cells were adoptive transfered into NOG mice via i.p. to assess allospecific immunosuppressive function of CD8+CD28– Ts in vivo. Suppression mechanisms of CD8+CD28– Ts were also investigated.

Results: In the presence of IL-15, the fraction and total number of CD8+CD28– T cells in CD8+ T cells increased dramatically, the number increased by 23.4±5.4 times after 9 days culture. Moreover, these expanded CD8+CD28– T cells could vigorously inhibit the proliferation of CD4+ T cells in contact dependent and donor-specific manner in vitro, and when transferred into NOG mice, their suppressive capacity kept steady in vivo. The expression of CD132, CD25 and PD-1 for CD8+CD28– Ts cells were up-regulated, while CD122, GZM-B and perforin expression were down-regulated. Interestingly, when anti-PD-1 or anti-PD-L1 was added into the culture system, suppress effect mediated by CD8+CD28– Ts cells was partially abolished when compared with isotype control.

Conclusions: Human allospecific CD8+CD28– Ts could be generated by IL-15 plus donor APCs in a relative short period of time in vitro, these cells could steadily exert their immunosuppressive function both in vitro and in vivo circumstances. Co-inhibitory signals PD-1:PD-L1 pathway play a role in the suppression mechanism.

CITATION INFORMATION: Feng F., Liu G., Zhu P., Zhu M., Lu X., Liu J., Luo X., Liu Y., Yu Y. Human CD8+CD28– T Cells Driven In Vitro by IL-15 Suppress in Allo-Specific Manner Partially through PD-1:PD-L1 Pathway Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Feng F, Liu G, Zhu P, Zhu M, Lu X, Liu J, Luo X, Liu Y, Yu Y. Human CD8+CD28– T Cells Driven In Vitro by IL-15 Suppress in Allo-Specific Manner Partially through PD-1:PD-L1 Pathway [abstract]. https://atcmeetingabstracts.com/abstract/human-cd8cd28-t-cells-driven-in-vitro-by-il-15-suppress-in-allo-specific-manner-partially-through-pd-1pd-l1-pathway/. Accessed June 3, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences